Could a diabetes pill protect kidneys from failing?
NCT ID NCT07116928
First seen Nov 18, 2025 · Last updated May 01, 2026 · Updated 20 times
Summary
This study tests whether adding ganagliflozin tablets to standard care can slow the worsening of kidney disease in adults with type 2 diabetes and chronic kidney disease. About 1,244 participants will receive either the drug or a placebo for 120 weeks. The main goal is to see if the drug helps preserve kidney function and delays the need for dialysis or a transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai sixth People's Hospital
Shanghai, Shanghai Municipality, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.